From the EMCDDA webpage
The EU drugs agency (EMCDDA) published updated national drug situation overviews for North Macedonia and Serbia. These reports are the result of an 8-month online capacity-building exercise, organised with the support of the Austrian Reitox national focal point Gesundheit Österreich (Austrian National Public Health Institute).
The report on the Republic of North Macedonia provides a top-level overview of the drug situation in the country, covering drug supply, use and public health problems as well as drug policy and responses. It brings together the most recent data available by the end of May 2022.
The report on Serbia provides a top-level overview of the drug phenomenon in this country, covering drug supply, use and public health problems as well as drug policy and health and social responses. The report contributes to a better understanding of the drug situation in Europe and is targeted at national and international audiences, including government, civil society, researchers and funders.
The reports are available following these links – North Macedonia – Serbia.